About Enhancer

Enhancer ID: E_02_0351
Species: human
Position : chr11:44561492-44563492
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: Kaposi s sarcoma
Pubmed ID:  32555380
Enhancer experiment: Immunohistochemistry (IHC) staining?RT-qPCR?western blotting?Luciferase reporter assay?Immunofluorescence assay (IFA)?DNA ChIP assay
Enhancer experiment description: Our results illustrate that, by hijacking Lef1 and CD82, vIRF1 upregulates CDCP1 to promote angiogenesis and cell invasion.

About Target gene

Target gene : CD82
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: Our results illustrate that, by hijacking Lef1 and CD82, vIRF1 upregulates CDCP1 to promote angiogenesis and cell invasion.

About TF

TF name : --
TF experiment: Immunohistochemistry (IHC) staining?RT-qPCR?western blotting?Luciferase reporter assay?Immunofluorescence assay (IFA)?DNA ChIP assay
TF experiment description: Our results illustrate that, by hijacking Lef1 and CD82, vIRF1 upregulates CDCP1 to promote angiogenesis and cell invasion.

About Function

Enhancer function : Our results illustrate that, by hijacking Lef1 and CD82, vIRF1 upregulates CDCP1 to promote angiogenesis and cell invasion.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
Our results illustrate that, by hijacking Lef1 and CD82, vIRF1 upregulates CDCP1 to promote angiogenesis and cell invasion.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs